A Mechanistic Study to Investigate tDCS and Working Memory in MCI Patients
University of Florida · with National Institute on Aging (NIA) · NCT05998031
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 60–95 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 110
- US sites recruiting
- 1
- Study start
- April 24, 2024
- Record last updated
- June 26, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The current study is a mechanistic study to evaluate working memory gains from application of transcranial direct current stimulation (tDCS) in older adults with mild cognitive impairments (MCI) compared to cognitively healthy control
Being studied: Active tDCS; Sham tDCS
Conditions: Cognitive Impairment; Cognitive Decline
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age 60-95 years
- Montreal Cognitive Assessment (MoCA) score 18 and above (scores will be adjusted for education)
- Able to receive electrical stimulation
- Ability to comprehend conversational voices
- Adequate motor capacity to operate computer mouse and click-button in-scanner
- Ability to participate in the intervention and attend training sessions Exclusion Criteria
- Failure to provide informed consent
- Contraindications to MRI recording (e.g., any kind of ferrous metallic stents or ferrous metal objects in the body, heart valve prosthesis, or other metal implants, claustrophobia, neurostimulation system, defibrillator, pacemaker, or other implanted device)
- Left-handed, or left hand dominant
- History of neurological, seizures, and psychiatric disorders, traumatic brain injury, incidence of stroke involving large vessel
- Terminal illness with life expectancy less than 12 months, as determined by physician
- Brain tumor or malformation or any foreign body known or previously identified in brain
- Cancer in active treatment, besides skin cancer
- Currently on GABAergic or glutamatergic medications, or on calcium or sodium channel blockers, which alter or block the ability of tDCS to facilitate tissue excitability
- Unable to communicate because of severe hearing loss or speech disorder
- Severe sensory impairment
- Inability to communicate in English
- Severe visual impairment, which would preclude completion of the assessment and/or intervention
- No physical impairment precluding motor response or lying still for an hour in the scanner that could confound study findings
- Moderate-to-severe depressive symptoms as defined by scoring 10 or above on the Geriatric Depression Scale (GDS)
Recruiting US locations
University of Florida
Gainesville, FL 32610
Site contact: Aprinda Indahlastari, PhD · 352-294-8990 · aimstudy@phhp.ufl.edu
Study contacts (from the official record)
- Aprinda I Queen, PhD · 3522948990 · aimstudy@phhp.ufl.edu
Similar studies in Florida
All neurology studies in Florida →- RecruitingHealthy volunteersPhase 1
A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease
Eli Lilly and Company
- Location
- Daytona Beach, FL
- Eligibility basics
- Ages 18–85
- RecruitingHealthy volunteersPhase 1
A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
Prevail Therapeutics
- Location
- Naples, FL + 1 other US site
- Eligibility basics
- Ages 30–80
- RecruitingHealthy volunteersPhase 1
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
Eli Lilly and Company
- Location
- Naples, FL + 7 other US sites
- Eligibility basics
- Ages 30–85
- RecruitingHealthy volunteersPhase 1
A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease
Eli Lilly and Company
- Location
- Daytona Beach, FL
- Eligibility basics
- Ages 18–85